Ownership Capital B.V. acquired a new stake in shares of Masimo Co. (NASDAQ:MASI) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 315,236 shares of the medical equipment provider’s stock, valued at approximately $39,259,000. Masimo makes up 2.3% of Ownership Capital B.V.’s investment portfolio, making the stock its 19th biggest position. Ownership Capital B.V. owned about 0.59% of Masimo at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Segall Bryant & Hamill LLC bought a new stake in shares of Masimo during the second quarter valued at about $1,280,000. Moody Aldrich Partners LLC bought a new stake in Masimo in the second quarter worth about $2,919,000. BancorpSouth Bank bought a new stake in Masimo in the second quarter worth about $212,000. RTW Investments LP raised its position in Masimo by 7.6% in the second quarter. RTW Investments LP now owns 249,543 shares of the medical equipment provider’s stock worth $24,368,000 after acquiring an additional 17,543 shares in the last quarter. Finally, Epoch Investment Partners Inc. bought a new stake in Masimo in the second quarter worth about $3,356,000. Institutional investors and hedge funds own 83.22% of the company’s stock.
MASI has been the topic of several research reports. BidaskClub cut shares of Masimo from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 3rd. Stifel Nicolaus boosted their price target on shares of Masimo from $112.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, October 2nd. Needham & Company LLC initiated coverage on shares of Masimo in a research report on Friday, September 14th. They issued a “buy” rating on the stock. Zacks Investment Research cut shares of Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, August 1st. Finally, Piper Jaffray Companies boosted their price target on shares of Masimo to $120.00 and gave the stock a “neutral” rating in a research report on Thursday, November 1st. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $114.40.
In related news, insider Ramshorst David J. Van sold 2,675 shares of Masimo stock in a transaction dated Monday, September 24th. The stock was sold at an average price of $122.87, for a total value of $328,677.25. Following the transaction, the insider now owns 2,325 shares of the company’s stock, valued at approximately $285,672.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Joe E. Kiani sold 126,927 shares of Masimo stock in a transaction dated Friday, August 31st. The stock was sold at an average price of $117.85, for a total value of $14,958,346.95. Following the completion of the transaction, the chief executive officer now directly owns 236,061 shares in the company, valued at approximately $27,819,788.85. The disclosure for this sale can be found here. Insiders sold a total of 666,033 shares of company stock worth $79,900,568 in the last three months. 12.60% of the stock is currently owned by company insiders.
Shares of Masimo stock opened at $118.00 on Friday. Masimo Co. has a 52 week low of $80.69 and a 52 week high of $126.89. The stock has a market capitalization of $6.09 billion, a price-to-earnings ratio of 48.16, a price-to-earnings-growth ratio of 2.70 and a beta of 1.11.
Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Wednesday, October 31st. The medical equipment provider reported $0.71 EPS for the quarter, topping the consensus estimate of $0.69 by $0.02. The firm had revenue of $210.58 million for the quarter, compared to analysts’ expectations of $207.62 million. Masimo had a net margin of 17.08% and a return on equity of 20.29%. Masimo’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.56 earnings per share. On average, equities analysts anticipate that Masimo Co. will post 2.92 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This news story was first published by Macon Daily and is the property of of Macon Daily. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://macondaily.com/2018/11/09/ownership-capital-b-v-acquires-shares-of-315236-masimo-co-masi.html.
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Recommended Story: Understanding Market Liquidity
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.